- Home
- Commercial Education
- Pharmaceutical & Medical Technology
- Global Expertise
- About Us
- Current Assignments
-
News & Blog
- Podcast 01 - What is the key to a successful partnership at a university?
- Podcast 02 - The future of UK Higher Education
- Podcast 03 - Building a successful education technology business
- Podcast 04 - How are education providers responding to increasing student expectations?
- Podcast 05 - Challenges and Opportunities for International School operator
- Podcast 06 - Doing it for Real
- Podcast 10 - The evolution of international education
- Podcast 10 - The changing dynamic of the return on investment for Higher Education students in the UK
- A view on the international schools market in the UAE.
- Podcast 07 - What are the challenges in building successful international clinical organisations?
- Podcast 08 - Education technology and a wider view on the academic publishing market
- Building successful eclinical businesses.
- Understanding the ELT market across ASEAN
- Decentralised/Hybrid/Virtual Trials - Hype or The New Norm?
- The Spencer Group: Our response to recruiting during the pandemic
- What is the key to leading a successful school in UAE through the pandemic?
- What implications will coronavirus have on Real World Evidence/data and the wider eclinical market?
- What implications will coronavirus have on higher education?
- Neil Rotherham: What is the impact of Covid-19 on the pharmaceutical technology market?
- What is impact of Covid-19 on school groups in China?
- What is the impact of Covid-19 on the international K-12 sector?
- What are the possible short, medium and long-term implications of Covid on the pharma sector?
- What have schools learnt when taking education online during Covid-19?
- What are the implications of Covid-19 on RBM and the wider pharmatech market?
- What are the implications of Covid-19 on the eCOA market?
- What are the possible implications of Covid-19 on the pharmaceutical technology sector?
- What are the possible implications of Covid-19 to Management Consultancy and to Higher Education?
- What are the possible implications of Covid-19 across the investment space in education?
- Dominic Farmer: A view on the possible implications of Covid-19 on the pharmatech sector.
- What are the possible implications of Covid-19 on the global education sector?
- What are the possible implications of Covid-19 on the biopharmaceutical and pharmatech markets?
- What are the possible implications of Covid-19 on the biopharmaceutical and the wider pharmaceutical markets?
- What are the possible implications of Covid-19 on edtech and the wider education environment?
- What are the effects of Covid-19 on pharma and the wider pharmatech space?
- What are the possible implications of Covid-19 on the wider healthcare space?
- What are the possible implications of Covid-19 on language education globally?
- What are the possible implications of Covid-19 on the wider education space?
- Decentralised trials, is this the new normal for clinical trials?
- A view on edtech in the US and the wider global education space.
- Education post lockdown – How are schools reopening in a socially distanced environment?
- How has Covid-19 effected global higher education?
- How should this year’s A Level results be managed fairly?
-
News & Blog
- Podcast 01 - What is the key to a successful partnership at a university?
- Podcast 02 - The future of UK Higher Education
- Podcast 03 - Building a successful education technology business
- Podcast 04 - How are education providers responding to increasing student expectations?
- Podcast 05 - Challenges and Opportunities for International School operator
- Podcast 06 - Doing it for Real
- Podcast 10 - The evolution of international education
- Podcast 10 - The changing dynamic of the return on investment for Higher Education students in the UK
- A view on the international schools market in the UAE.
- Podcast 07 - What are the challenges in building successful international clinical organisations?
- Podcast 08 - Education technology and a wider view on the academic publishing market
- Building successful eclinical businesses.
- Understanding the ELT market across ASEAN
- Decentralised/Hybrid/Virtual Trials - Hype or The New Norm?
- The Spencer Group: Our response to recruiting during the pandemic
- What is the key to leading a successful school in UAE through the pandemic?
- What implications will coronavirus have on Real World Evidence/data and the wider eclinical market?
- What implications will coronavirus have on higher education?
- Neil Rotherham: What is the impact of Covid-19 on the pharmaceutical technology market?
- What is impact of Covid-19 on school groups in China?
- What is the impact of Covid-19 on the international K-12 sector?
- What are the possible short, medium and long-term implications of Covid on the pharma sector?
- What have schools learnt when taking education online during Covid-19?
- What are the implications of Covid-19 on RBM and the wider pharmatech market?
- What are the implications of Covid-19 on the eCOA market?
- What are the possible implications of Covid-19 on the pharmaceutical technology sector?
- What are the possible implications of Covid-19 to Management Consultancy and to Higher Education?
- What are the possible implications of Covid-19 across the investment space in education?
- Dominic Farmer: A view on the possible implications of Covid-19 on the pharmatech sector.
- What are the possible implications of Covid-19 on the global education sector?
- What are the possible implications of Covid-19 on the biopharmaceutical and pharmatech markets?
- What are the possible implications of Covid-19 on the biopharmaceutical and the wider pharmaceutical markets?
- What are the possible implications of Covid-19 on edtech and the wider education environment?
- What are the effects of Covid-19 on pharma and the wider pharmatech space?
- What are the possible implications of Covid-19 on the wider healthcare space?
- What are the possible implications of Covid-19 on language education globally?
- What are the possible implications of Covid-19 on the wider education space?
- Decentralised trials, is this the new normal for clinical trials?
- A view on edtech in the US and the wider global education space.
- Education post lockdown – How are schools reopening in a socially distanced environment?
- How has Covid-19 effected global higher education?
- How should this year’s A Level results be managed fairly?
13 May 2020
Dominic Farmer: A view on the possible implications of Covid-19 on the pharmatech sector.
Dominic Farmer has been in the industry for 25 years having established Cisiv, a leading player in late phase and real world evidence solutions, in 1998. In this podcast, Dominic discusses his view on the possible implications of Covid-19 on the pharmaceutical technology space.
For more information on Dominic Farmer or Cisiv, please click here.
Listen to the Podcast below:
Services
Services
The Spencer Group
9 Greyfriars Road,
Reading,
Berkshire,
RG1 1NU
t: +44 (0)118 935 9444
e: info@spencergroup.com
Copyright © Spencer Group 2020
Website by Supreme